MedTrace Logo

Peripheral Artery Disease in Vastmanland

NCT01452165 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 457

Last updated 2020-05-08

No results posted yet for this study

Summary

The main purposes of this study are:

* to describe the prevalence and degree of reduced left ventricular function and hypertrophy in patients with peripheral arterial disease in comparison to controls from the general population,
* to evaluate factors of importance to left ventricular dysfunction and hypertrophy in patients with peripheral arterial disease, and
* to assess the impact of cardiac function and left ventricular hypertrophy on long-term prognosis in patients with peripheral artery disease.

Conditions

  • Peripheral Vascular Diseases
  • Heart Failure
  • Ventricular Dysfunction

Sponsors & Collaborators

  • Västmanland County Council, Sweden

    collaborator OTHER_GOV

  • Uppsala University

    lead OTHER

Principal Investigators

  • Pär Hedberg, Assoc. Professor · Center of Clinical Research, Uppsala university, Central Hospital, SE-72189 Västerås, Sweden

  • Jerzy Leppert, Senior Professor · Center of Clincial Research, Uppsala university, Central Hospital, SE-72189 Västerås, Sweden

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01452165 on ClinicalTrials.gov